EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Multizentrische StudieOpen Access · CC BY 4.0

Efficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial

Akihiro Tokushige iD, Yuichi Akasaki iD, Keisuke Shibata, Takashi Sakoda, Akari Tajima, Takashi Kajiya iD, Naohiro Shirasawa, Narisato Hamada, Akiko Yoshikawa, Kazuyuki Kubota, Tsuminori Yamashita, Kenjuro Higo und 7 weitere

Nutrients · 03.06.2026 · 18 (11) · 1801

DOI: 10.3390/nu18111801 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 03.06.2026. Verfasst von Akihiro Tokushige und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Raphanus, Plant Extracts. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jufuku Sangyo Co., Ltd., Take Yakuhin Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: We aimed to evaluate the efficacy and safety of a short-term dietary intervention using trigonelline-rich Sakurajima radish on vascular endothelial function in patients with metabolic syndrome (MetS).

Methods

In this multicenter, open-label, randomized, three-period crossover phase IIb trial, 21 patients with MetS were assigned to three 14-day sequences (Sakurajima radish powder, Aokubi radish powder, and a usual diet), separated by 14-day washouts. The primary outcome was flow-mediated dilation (FMD). Key Secondary outcomes included blood pressure (BP), urinary nitric oxide metabolites (NOx), and the oxidative stress marker 8-hydroxy-2′-deoxyguanosine (8-OHdG).

Results

Sakurajima radish did not improve FMD versus the usual diet (p = 0.58) or Aokubi radish (p = 0.59), although a significant negative carryover effect following the Aokubi period likely confounded this estimation. Despite successfully stimulating NO production (elevated urinary NOx, p = 0.03), the intervention paradoxically increased oxidative stress (elevated 8-OHdG/creatinine, p = 0.02) and significantly elevated systolic BP compared with the usual diet (+9.67 mmHg, p = 0.03) and Aokubi radish (+8.86 mmHg, p = 0.04).

Conclusions

Sakurajima radish does not appear to improve endothelial function in patients with MetS within the constraints of this short-term crossover design. Importantly, the unexpected negative carryover effect inherently limits the interpretability of this primary FMD outcome, as it may have masked potential physiological benefits. Despite boosting NO production, the intervention paradoxically exacerbated systemic oxidative stress and elevated systolic BP. These findings suggest that in the pro-oxidant environment of MetS, NO-boosting functional foods may induce unintended adverse hemodynamic responses, underscoring the need for careful risk–benefit evaluation and parallel-group trial designs in this specific population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeRaphanusPlant ExtractsHumansCross-Over StudiesOxidative StressMaleFemaleMiddle AgedBlood PressureEndothelium, VascularAlkaloidsAdultNitric OxideTreatment Outcome

Stichwörter der Autor:innen

Sakurajima radishflow-mediated dilationmetabolic syndrometrigonelline

Substanzen

trigonellineAlkaloidsPlant ExtractsNitric Oxide

Autor:innen und Institutionen

  • Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
  • Department of Clinical Pharmacology and Therapeutics, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan.
  • Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
  • Tenyoukai Central Hospital, Kagoshima 892-0822, Japan.
  • Keizankai Kyoritsu Hospital, Kagoshima 890-0069, Japan.
  • Jinaikai Ueyama Hospital, Kagoshima 890-0073, Japan.

ORCID-Profile: Akihiro Tokushige, Yuichi Akasaki, Takashi Kajiya, Kouta Funakoshi, Ryota Kawai, Hisako Yoshida, Katsuko Kajiya

Förderung

  • Jufuku Sangyo Co., Ltd.
  • Take Yakuhin Co., Ltd.

Zitieren

APA

Tokushige, A., Akasaki, Y., Shibata, K., Sakoda, T., Tajima, A., Kajiya, T., Shirasawa, N., Hamada, N., Yoshikawa, A., Kubota, K., Yamashita, T., Higo, K., Kubozono, T., Funakoshi, K., Kawai, R., Yoshida, H., Shintani, A., Kajiya, K., & Ohishi, M. (2026). Efficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial. Nutrients, 18(11), 1801. https://doi.org/10.3390/nu18111801

Vancouver

Tokushige A, Akasaki Y, Shibata K, Sakoda T, Tajima A, Kajiya T, et al. Efficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial. Nutrients. 2026;18(11):1801. doi:10.3390/nu18111801

BibTeX
@article{Tokushige2026,
  author = {Tokushige, Akihiro and Akasaki, Yuichi and Shibata, Keisuke and Sakoda, Takashi and Tajima, Akari and Kajiya, Takashi and Shirasawa, Naohiro and Hamada, Narisato and Yoshikawa, Akiko and Kubota, Kazuyuki and Yamashita, Tsuminori and Higo, Kenjuro and Kubozono, Takuro and Funakoshi, Kouta and Kawai, Ryota and Yoshida, Hisako and Shintani, Ayumi and Kajiya, Katsuko and Ohishi, Mitsuru},
  title = {Efficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1801},
  doi = {10.3390/nu18111801}
}
Kostenlos starten →